Supreme Court to Rule on Health Reform Legality
The US Supreme Court, as expected, is set to decide if key provisions of the Obama administration’s health care overhaul law violate the Constitution by exceeding the federal government’s power to regulate interstate commerce and to levy taxes. Justices indicated that they will hear oral arguments in March 2012, which would lead to a ruling on the case in June, just four months prior to the November presidential elections …Read more
Help Us Build Pharma Faceoff's 2012 Season
Get in on the ground floor and help us develop new topics, find experts and create the can’t miss Pharma video program for 2012 ...Read more Drug 'Fact Box' Quiz: You Decide
A growing body of academic literature — and FDA’s Risk Communication and Advisory Committee — suggests that drug fact boxes would help doctors and consumers evaluate new drugs more effectively, that is to say, scientifically. Do you agree? Take the quiz to find out ...Read More
Aligning Patients and Payers Incentives
Pharmaceutical and biotechnology companies need to demonstrate innovation and differentiation as they launch new products to market. Patients are at the center of this debate as they want to be more empowered in their search for quality care and informed of alternatives for potential treatment. The creation of the US-based Patient-Centered Outcomes Research Institute (PCORI) aims to embody this new patient role ...Read More
Recognizing 'Real Innovation': An IMI Update
There is a risk that the currency of terms like ‘innovation’ has been devalued by over-use. But one organization at least has come a little closer to matching words with deeds. Europe’s grandly titled Innovative Medicines Initiative (IMI) last month provided an overview of some of its achievements—and some of them merit recognition ...Read More |
